Global Autologous Cell Therapy Product Market ($ 34.8 Bn by 2028) Growth Forecast at 17.1% CAGR During 2022 to 2028 COVID-19 Impact and Global Analysis by Vantage Market Research

WASHINGTON, March 04, 2022 (GLOBE NEWSWIRE) -- Recently, the Autologous Cell Therapy Product Market is changing the face of the medicinal treatment and therapeutics. The major factors driving the autologous cell therapy products is the increasing number of chronic diseases such as heart disease, cancer, diabetes, stroke, and arthritis. This is owing to the rising population of cities and unhealthy lifestyle. Major manufacturing companies are funding in Research and Development (R&D) institutes and organisations for developing drugs for autologous cell therapy products. This are some of the driving factors which are expected to generate revenue for Autologous Cell Therapy Product Market in near future, states Vantage Market Research, in a report, titled “Autologous Cell Therapy Product Market by Source (Bone Marrow, Epidermis), by End User (Hospitals, Ambulatory Centers, Research Centers), by Application (Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”.

The market size stood at USD 10.54 Billion in 2021. The Global Autologous Cell Therapy Product Market size is anticipated to reach USD 34.8 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 17.1% during the forecast period.

Please Check Out Our Free Sample Reports and Make a More Informed Decision:

Get Access to a Free Copy of Our Latest Sample Report @

(Sample reports are a great way to test our in-depth reports or study before you make a purchase)

  • The newly updated, 150+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.
  • Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.
  • We offer these reports in PDF format so you can read them on your computer and print them out.
  • Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter's 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.
  • The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.
  • Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.

The report on Autologous Cell Therapy Product Market highlights:

  • Assessment of the market
  • Premium Insights
  • Competitive Landscape
  • COVID Impact Analysis
  • Value Chain Analysis
  • Historic Data, Estimates and Forecast
  • Company Profiles
  • Porter’s Five Forces Analysis
  • Global and Regional Dynamics

Market Overview:

Rise in the Population Suffering from Chronic Diseases to flourish market

The rising number of people encountering severe conditions has initiated a requirement for autologous cell therapy. This treatment is considered to have moderate risk of complications and hence when compared to other treatments proves to be a better solution. As a consequence of growing population in cities and modern lifestyle, outbreak of various diseases is observed. Majority of the population is suffering from diseases such as diabetes, heart diseases, cancer, and others. Recent study shows that around 30 million Americans are facing heart diseases every year and 45% of them result in fatality. Autologous cell therapy technology has shown extraordinary results in recent years, this includes faster treatment, lower risks of side effects, healthier treatment, and many other benefits. These are some of the features of autologous cell therapy which is driving the Autologous Cell Therapy Product Market.   

Purchase This Premium Report Now @

Benefits of Purchasing Autologous Cell Therapy Product Market Reports:

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
  • Assured Quality: Focuses on accuracy and quality of reports.
  • Incomparable Skills: Analysts provide in-depth insights into reports.

High Cost and Lower Treatment Facilities is expected to hinder the Autologous Cell Therapy Product Market

Autologous cell therapies are a growing area of interest for the treatment of a number of treatments for neurological, cardiovascular, arthritis and various other diseases which are refractory to other more conventional drug therapies. The biggest disadvantages of the autologous cell therapy treatment are its high cost and fewer healthcare facilities for treatment. The cost for autologous cell therapies is higher owing to its management of patient’s hospital setting, manufacture of the agents used to activate the cells, logistics, and risk analysis. These make the therapy costly and hence to some extent might hinder the Autologous Cell Therapy Product Market Growth.

COVID-19 Impact Analysis:

The COVID-19 outbreak has affected various industries worldwide. The Autologous Cell Therapy Product Market also had a huge impact. Governments across the world took severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to stop the swift spread of COVID-19. These actions led to a severe impact on the global economy impairing various industries. Moreover, reduced manufacturing activities further affected the demand for autologous cell therapy products across the globe.  The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data- points:

  1. Impact Assessment of COVID-19 Pandemic
    1. North America
    2. Europe
    3. Asia Pacific
    4. Latin America
    5. Middle East & Africa
  2. Quarterly Market Revenue Forecast by Region 2020 & 2021
  3. Key Strategies Undertaken by Companies to Tackle COVID-19
  4. Long Term Dynamics
  5. Short Term Dynamics

Read Full Research Report @

Regional Analysis:

Increasing Growth of Autologous Cell Therapy Product Market in North America

North America garnered high revenue share owing to high adoption of autologous cell therapy technology and increase in adoption toward advanced healthcare technology products. This is a major factor to drive the growth of the Autologous Cell Therapy Product Market forecast in this region. Moreover, many patients in the region are inclining toward adopting autologous cell therapy helping them to recover faster and proving to be a better treatment for curing diseases.  

The Asia Pacific is expected to grow at the fastest rate during the forecast period, owing to the prevalence for increase in number of well-established autologous cell therapy facilities. This region contributes to have major research institutes and R&D facilities which are further fuelling the growth of the market. A large number of on-going research studies and growth of the overall healthcare sector on a global scale are among the few factors expected to contribute to the growth of this market.

For instance, in December 13, 2021 — Novartis announced the introduction of T-Charge, the company’s next-generation CAR-T platform that will serve as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline. The T-Charge platform preserves T cell stemness, the ability to self-renew and mature, which results in a product containing greater proliferative potential and fewer exhausted T cells. With T-Charge, CAR-T cell expansion occurs primarily within a patient’s body, eliminating the need for an extended culture time outside of the body. These unique characteristics of the T-Charge platform may lead to better and more durable responses, improved long-term outcomes and a reduced risk of severe adverse events.

Browse market data Tables and Figures spread through 156 Pages and in-depth TOC on "Autologous Cell Therapy Product Market by Source (Bone Marrow, Epidermis), by End User (Hospitals, Ambulatory Centers, Research Centers), by Application (Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)" View detailed Research Report here -

List of Prominent Players in the Autologous Cell Therapy Product Market:

  • Vericel Corporation (US)
  • Pharmicell Co. Inc (South Korea)
  • Holostem Terapie Avanzate S.R.L (Italy)
  • Lineage Cell Therapeutics Inc. (US)
  • Opexa Therapeutics (US)

Key questions answered in the report:

  • Which regional market will show the highest and rapid growth?
  • Which are the top five players of the Autologous Cell Therapy Product Market?   
  • How will the Autologous Cell Therapy Product Market change in the upcoming six years?  
  • Which application and product will take a lion’s share of the Autologous Cell Therapy Product Market?       
  • What is the Autologous Cell Therapy Product market drivers and restrictions?    
  • What will be the CAGR and size of the Autologous Cell Therapy Product Market throughout the forecast period?     

This market titled “Autologous Cell Therapy Product Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:

Report AttributeDetails
Market Size in 2021USD 10.54 Billion
Projected Market Size in 2028USD 34.8 Billion
CAGR Growth RateCAGR of 17.1% From 2022 – 2028
Base Year2021
Historic Years2016 - 2020
Forecast Years2022 - 2028
Segments CoveredSource

     • Bone Marrow

     • Epidermis

End User

     • Hospitals

     • Ambulatory Centers

     • Research Centers


     • Cancer

     • Neurodegenerative Diseases

     • Wound Healing

     • Orthopedic

     • CVD

     • Autoimmune Diseases

Quantitative Data - UnitsRevenue in USD Million/Billion and CAGR from 2021 to 2028
Regions CoveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries CoveredU.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Report CoverageMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Download Free Sample Report Now @

Browse More Related Report:

About Vantage Market Research:

Vantage Market Research is a reputed company committed to providing high quality data and market research services. The company provides quantified B2B high quality research on more than 20,000 emerging markets. The company offers detailed reports on multiple industries including chemical materials and energy, food and beverages, healthcare, technology, etc. The company comprises over 125 analysts and consultants, adding more than 1,100 market research reports to its vast database every year. The company’s clientele base spans across 70% of the Global Fortune 500 companies.

Follow Us on LinkedIn:

Follow Us on Twitter:

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727



Latest Vantage Market Research Press Releases @

Latest Vantage Market Research Blog @